Bibliographic Details
| Title: |
Real-World Experience of Bimekizumab in an Elderly Patients Cohort with Plaque-Type Psoriasis: A 24-Week Retrospective Study. |
| Authors: |
Fratton, Zeno, Maione, Vincenzo, Bighetti, Stefano, Bettolini, Luca, Arisi, Mariachiara, Stinco, Giuseppe, Errichetti, Enzo |
| Source: |
Clinical, Cosmetic & Investigational Dermatology; Sep2024, Vol. 17, p2177-2181, 5p |
| Subject Terms: |
REGULATORY T cells, OLDER patients, OLDER people, TERMINATION of treatment, CHRONIC kidney failure |
| Abstract: |
This article presents the findings of a 24-week retrospective study that aimed to evaluate the efficacy and safety of bimekizumab (BKZ) in elderly patients with moderate-to-severe plaque psoriasis. The study involved 15 elderly patients who were treated with BKZ, and the results showed a significant decrease in Psoriasis Area and Severity Index (PASI) scores over the course of the study. The treatment was well tolerated, with only two patients discontinuing due to minor adverse events. The study suggests that BKZ is an effective treatment option for elderly patients with plaque psoriasis. However, further research with larger cohorts and longer follow-up periods is needed to validate these findings. [Extracted from the article] |
|
Copyright of Clinical, Cosmetic & Investigational Dermatology is the property of Dove Medical Press Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
